Skip to Main Content
Asal Rahimi, M.D.

Asal Rahimi, M.D.

Associate Vice Chair for Program Development, Medical Director of the SCCC Clinical Research Office, Chief of Breast Radiation Oncology Service

Professor

School
Medical School
Department
Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Treating breast cancer patients with radiation therapy is the sole clinical focus for Asal Rahimi, M.D., M.S. Her experience in this area gives her the tools necessary to answer patient questions openly and honestly. Preparing for radiation treatment, or any kind of cancer treatment, can be scary, she says, and spending time with patients until they feel comfortable with their treatment plan is an important part of the process.

    Dr. Rahimi is Chief of Breast Radiation Oncology Service, Medical Director of the SCCC Clinical Research Office, and Associate Vice Chair for Program Development. She joined the Department of Radiation Oncology in August 2011 after concluding her residency in radiation oncology at the University of Virginia and completing special training with the American Brachytherapy Society that same year.

    Over the last decade, radiation treatment for breast cancer has been moving from treatment of the whole breast toward the (still investigational) option of partial breast irradiation, which was the focus of the special training Dr. Rahimi completed with the American Brachytherapy Society. This approach exposes the heart, lungs, and skin to less unnecessary radiation and can be delivered via interstitial brachytherapy, balloon brachytherapy, or external beam radiation therapy.

    The GammaPod radiotherapy system at UT Southwestern, one of the first such systems in the United States, is a platform for stereotactic radiation, like the Gamma Knife for brain tumors, that immobilizes the breast and allows for higher doses of radiation to the breast tumor in fewer visits.

    “The GammaPod will give us a non-invasive tool for partial breast cancer radiation treatments,” says Dr. Rahimi. “I know my patients would appreciate that. It’s less disrupting to their lives outside of their cancer.”

    Clinical Interests

    • Breast cancer radiation therapy
    • Partial breast irradiation
    • Deep inspiratory breath hold
    • Invasive brachytherapy
    • Non-invasive radiation therapy
    • GammaPod
    • Hypofractionation/hypofractionated radiation treatment

  • Education
    Graduate School
    Finch University of Health Sciences-Chicago Medical School (2002)
    Medical School
    Rosalind Franklin University of Medicine & Science (2006)
    Internship
    University of Virginia Medical Center (2007), Internal Medicine
    Residency
    University of Virginia Medical Center (2011), Radiation Oncology
  • Publications
    Reply to G.B. Mann et al and S. Sorscher
    Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M Journal of Clinical Oncology 2024 Jun 42 1998-2000
    Multimodal radiotherapy dose prediction using a multi-task deep learning model
    Maniscalco A, Mathew E, Parsons D, Visak J, Arbab M, Alluri P, Li X, Wandrey N, Lin MH, Rahimi A, Jiang S, Nguyen D Medical physics 2024 Jun 51 3932-3949
    Master Breast Radiation Planning: Simple Guide for Radiation Oncology Residents
    Arbab M, Frame R, Alluri P, Parsons D, Lin MH, Cleaton J, Rahimi A Advances in Radiation Oncology 2024 Jun 9
    Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
    Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M Journal of Clinical Oncology 2024 Feb 42 390-398
    Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer
    Simmons A, Sher DJ, Kim DD, Leitch M, Wooldridge RD, Goudreau S, Seiler SJ, Neufeld S, Stein M, Albuquerque K, Spangler AE, Heinzerling J, Garwood D, Stevenson S, Ahn C, Ding C, Timmerman R, Rahimi AS Practical Radiation Oncology 2024
    Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
    Udden SM, Baek GH, Pandey K, Vidal C, Liu Y, Rahimi AS, Kim DN, Nwachukwu C, Mani RS, Alluri PG npj Precision Oncology 2023 Dec 7
    Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer
    Miljanic M, Nwachukwu C, Rahimi A Journal of Cancer Research and Clinical Oncology 2023 Nov 149 15553-15559
    Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy
    Johns C, Montalvo SK, Cauble MK, Liu YL, All S, Rahimi AS, Alluri PG, Leitch M, Unni N, Wooldridge RD, Farr D, Nwachukwu C, Kim DW Breast Cancer Research and Treatment 2023 Jun 199 381-387
    A deep learning approach for automatic delineation of clinical target volume in stereotactic partial breast irradiation (S-PBI)
    Kazemimoghadam M, Yang Z, Chen M, Rahimi A, Kim N, Alluri P, Nwachukwu C, Lu W, Gu X Physics in medicine and biology 2023 May 68
    Stability and reproducibility comparisons between deep inspiration breath-hold techniques for left-sided breast cancer patients: A prospective study
    Parsons D, Joo M, Iqbal Z, Godley A, Kim N, Spangler A, Albuquerque K, Sawant A, Zhao B, Gu X, Rahimi A Journal of applied clinical medical physics 2023 May 24
  • Honors & Awards
    • ARRO Educator of the Year
      The award is presented in partnership with ASTRO for the recognition of excellence in teaching, enthusiasm, and support for radiation oncology residency training. (2013)
    • American Brachytherapy Society and Nucletron Sponsored HDR Fellowship
      Arizona Breast Cancer Specialist breast HDR specialty training (2011)
    • RSNA Resident Fellowship Research Award
      (2010)
    • University of Virginia Resident Clinical Excellence Award
      Resident Clinical Excellence Award (2009)
    • MD with Distinction in Research
      Research Honor Thesis (2006)
    • Alpha Omega Alpha
      Honor Society (2005)
  • Professional Associations/Affiliations
    • American Brachytherapy Society (2010)
    • American Society of Clinical Oncology (2007)
    • American Society Therapeutic Radiation Oncology (2007)
    • NRG National Breast Committee (2015)
    • Radiological Society of North America